(R)-2-(6-Benzhydrylpyridin-2-yl)-4-(tert-butyl)-4,5-dihydrooxazole, 97%, 1g

4-(2-(pyridin-4-yl)vinyl)phenol, 95.0%, 250mg

9-Bromo-10-(1,1':3',1''-terphenyl-5'-yl)anthracene>98.0%(HPLC)1g

3-((2-Hydroxyethyl)amino)benzoic acid, 97%, 250mg

4-bromo-1,5-dimethyl-1H-pyrrole-2-carbonitrile, 95.0%, 100mg

1-Hydroxy-1,3-dioxo-1,3-dihydro-1l5-benzo[d][1,2]iodoxole-4-carboxylic acid, 97.0%, 5g

3-(4-Nitrophenoxy)pyrrolidine, 95+%, 5g

Dysprosium ICP standard solution, ROTI®Star, 10000 mg/l Dy, density (D) ~1 g/cm³

Ion exchange resin ROTI®Change 1 x 2, 25 g

2-CHLORO-5-(1-METHYL-PIPERIDIN-4-YLMETHOXY)-PYRIMIDINE, 95.0%, 250mg

5-Chloro-2-(trifluoromethyl)benzyl alcohol, 95.0%, 1g

R-(+)-LANSOPRAZOLE, 97.0%, 250mg

1-Methyl-cyclobutylamine hydrochloride, 95.0%, 10g